Correlation Between NLS Pharmaceutics and Ascletis Pharma
Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and Ascletis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and Ascletis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NLS Pharmaceutics AG and Ascletis Pharma, you can compare the effects of market volatilities on NLS Pharmaceutics and Ascletis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of Ascletis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and Ascletis Pharma.
Diversification Opportunities for NLS Pharmaceutics and Ascletis Pharma
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NLS and Ascletis is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and Ascletis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascletis Pharma and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with Ascletis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascletis Pharma has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and Ascletis Pharma go up and down completely randomly.
Pair Corralation between NLS Pharmaceutics and Ascletis Pharma
Assuming the 90 days horizon NLS Pharmaceutics AG is expected to generate 8.06 times more return on investment than Ascletis Pharma. However, NLS Pharmaceutics is 8.06 times more volatile than Ascletis Pharma. It trades about 0.06 of its potential returns per unit of risk. Ascletis Pharma is currently generating about -0.21 per unit of risk. If you would invest 1.40 in NLS Pharmaceutics AG on September 13, 2024 and sell it today you would lose (0.31) from holding NLS Pharmaceutics AG or give up 22.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NLS Pharmaceutics AG vs. Ascletis Pharma
Performance |
| Timeline |
| NLS Pharmaceutics |
| Ascletis Pharma |
NLS Pharmaceutics and Ascletis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NLS Pharmaceutics and Ascletis Pharma
The main advantage of trading using opposite NLS Pharmaceutics and Ascletis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, Ascletis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascletis Pharma will offset losses from the drop in Ascletis Pharma's long position.| NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
| Ascletis Pharma vs. Sino Biopharmaceutical Ltd | Ascletis Pharma vs. Defence Therapeutics | Ascletis Pharma vs. Aileron Therapeutics | Ascletis Pharma vs. Enlivex Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |